Thank you for sharing!

Your article was successfully shared with the contacts you provided.

A New Jersey appeals court has applied the state Supreme Court’s landmark 2018 Accutane ruling on admission of scientific evidence as the basis for reinstating two suits linking Johnson & Johnson’s talc products to ovarian cancer.

The appeals court ruling said the judge below erred by throwing out expert testimony on behalf of the plaintiffs based on his own opinions of their arguments’ merits, rather than on the scientific community’s views, as the Supreme Court held in the Accutane case.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Charles Toutant

Charles Toutant is a litigation writer for the New Jersey Law Journal.

More from this author


Drug and Medical Device Product Liability DeskbookBook

This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.

Get More Information

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.